Tale of a Man, a Worm and a Snail, A
CABI Publishing (Verlag)
978-1-78639-255-8 (ISBN)
Schistosomiasis is Africa's second most common parasitic disease. Less than 20 years ago, over 200 million were infected. In many high-risk areas the Schistosomiasis Control Initiative (SCI) has been helping to tackle the disease by offering treatments to millions of children. This book tells the story of a man, Alan Fenwick, who founded the SCI to control the worms and snails and so improve the lives of many burdened with the disease as well as reducing the numbers infected. Over this period SCI and the Ministries of Health and Education in 16 countries delivered over 220 million treatments. Treatment coverage of up to 75% has been achieved. Widely recognised as a cost-effective and successful intervention, SCI's knock-on effects include improving overall physical health, school attendance and future prospects for millions of people. The authors explore the work and experiences involved in forming, establishing and managing a health intervention system such as the SCI, while describing important lessons for anyone looking to replicate the success. This book covers: - Challenges faced and how the SCI overcame them to achieve its success; - Raising funds to deliver donated medicines; - Development of innovative partnerships; - Cultivation of working relationships and implementation across Africa; - A new model for other Neglected Tropical Disease programmes (NTDs); - Aspects of Alan's life in Africa told with memorable and often humorous anecdotes. A Tale of a Man, a Worm and a Snail is an essential resource for researchers, policymakers, health professionals and students of NTD control. The book is an enlightening, informative and enjoyable read for anyone interested in global health.
Alan Fenwick (Author) Professor Fenwick has been at Imperial College since June 2002 teaching Tropical Parasitology to medical students, on Bio Medical Science courses, Masters courses, and to Intercollated B.Sc. courses both at Imperial and in other UK Universities. A specialist in the research and control of Schistosomiasis, Professor Fenwick has been recognised for his achievements not only by the Queen with an OBE, but also in other countries notably Niger and Burkina Faso. He has lived and worked in Tanzania, Sudan and Egypt, prior to returning to UK and to Imperial College. He has received two life time medal awards from both the UK Royal Society of Tropical Medicine and Hygiene (RSTMH) and the US American Society for Tropical Medicine and Hygiene (ASTMH) The programme that Professor Fenwick established at Imperial in 2002 (SCI) has been recognised as a top medical programme by the award of the "Queens Anniversary Prize" in 2008. SCI is recommended to private donors as a top value charity by the independent evaluation teams at Oxford University www.givingwhatwecan.org and SCI is one of the top international charities recommended by www.givewell.org in USA. The reason for this recognition is that SCI has assisted 16 countries deliver over 130 million treatments with the medicine praziquantel to under privileged populations, especially to children thus preventing the development of serious illness in later life. All this has been achieved at an average cost of just 50 pence per child per year.
Chapter 1: My Early Years, My Education and My First Job Chapter 2: Schistosomiasis and the Amazing Life-cycle of a Killer Worm Chapter 3: Coming of Age in Tanzania – Arusha, 1966–1971 Chapter 4: Research, Training and Drug Testing in Sudan, 1971–1988 Chapter 5: Assisting the Control of Bilharzia in Egypt, 1988–2002 Chapter 6: An Ambitious Programme for Africa (from 2002) Chapter 7: Establishing SCI – The Early Days, 2002-2003 Chapter 8: The Big Three versus NTDs – Finding Common Purpose Chapter 9: Planning for Success Chapter 10: Across Borders - Implementing Schistosomiasis Control from East to West Africa Chapter 11: Schistosomiasis - Mapping the Disease Chapter 12: Drugs - Mobilising the African Marketplace to Paralyse the Worm Chapter 13: Advocacy and Promotion of SCI Activity Chapter 14: M&E – What is Measured and Reaching Out to Donors Chapter 15: Building Partnerships - High Stakes for High Rewards Chapter 16: The SCI Target - Low Infection Rates Chapter 17: Research - Forewarned is Forearmed Chapter 18: Recognition for SCI Work Chapter 19: Accelerating Control of NTDs and Schistosomiasis in Particular, 2008–2020 Chapter 20: The Last Mile Chapter 21: What Next for Alan?
| Erscheinungsdatum | 21.12.2021 |
|---|---|
| Verlagsort | Wallingford |
| Sprache | englisch |
| Maße | 172 x 244 mm |
| Gewicht | 772 g |
| Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Mikrobiologie / Infektologie / Reisemedizin |
| Studium ► Querschnittsbereiche ► Infektiologie / Immunologie | |
| ISBN-10 | 1-78639-255-0 / 1786392550 |
| ISBN-13 | 978-1-78639-255-8 / 9781786392558 |
| Zustand | Neuware |
| Haben Sie eine Frage zum Produkt? |
aus dem Bereich
